By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ContraFect Corporation 

28 Wells Avenue, Third Floor

Yonkers  New York   10701  U.S.A.
Phone: 914-207-2300 Fax: n/a



Company News
ContraFect Corporation (CFRXU)'s Universal Influenza Treatment Receives SBIR Funding 9/17/2014 12:35:55 PM
ContraFect Corporation (CFRXU) Announces Separation Of Units Sold In IPO 9/9/2014 11:12:12 AM
ContraFect Corporation (CFRXU) To Present At Rodman & Renshaw 16th Annual Healthcare Conference 9/4/2014 1:04:03 PM
ContraFect Corporation (CFRXU) Showcases CF-301 At ICAAC 2014 Meeting In Washington, D.C. 9/3/2014 2:26:37 PM
ContraFect Corporation (CFRXU) Announces Closing Of Initial Public Offering 8/4/2014 11:26:56 AM
ContraFect Corporation (CFRXU) To Ring The NASDAQ Stock Market Opening Bell 7/30/2014 7:41:26 AM
New York Biotech ContraFect Corporation (CFRXU) Prices Upsized IPO At $5-6 A Share 7/29/2014 6:02:34 AM
Journal of Infectious Diseases Publishes ContraFect Corporation's Scientific Research 5/13/2014 9:30:41 AM
ContraFect Corporation Brings In Ex-Five Prime Therapeutics, Inc. (FPRX)'s Chief For Top Post 4/24/2014 7:23:06 AM
ContraFect Corporation Completes $11.8 Million Financing 9/4/2013 8:37:03 AM